Javascript must be enabled to continue!
Plasmatic NT-proBNP is strongly associated with atrial fibrillation in patients with Implantable cardioverter defibrillator
View through CrossRef
Abstract
Background and objectives
Atrial fibrillation is common in patients with chronic heart failure and associated with poor outcome in these patients. Plasmatic NT-proBNP represents the gold standard biomarker for chronic heart failure. Further, recent studies showed prognostic impact of urinary NT-proBNP. Aim of the study was to assess the association of plasmatic as well as urinary NT-proBNP and atrial fibrillation in a cohort of patients with implantable cardioverter defibrillator (ICD).
Methods
412 patients were included in the study. Fresh spot urine and blood samples were used to assess urinary as well as plasmatic NT-proBNP. Urinary NT-proBNP was normalized to urinary creatinine. Follow-up was performed after 45 months. Heart rhythm history was evaluated and a 12-lead electrocardiogram was performed at enrollment (sinus rhythm (SR, n = 306), atrial fibrillation (AFib, n = 79)).
Results
Patients suffering from atrial fibrillation showed significant higher age, reduced left ventricular ejection fraction (LVEF), higher rates of chronic kidney disease, hypertension and urinary as well as plasmatic NT-proBNP compared to patients with sinus rhythm (each p < 0.05). There were no differences regarding Diabetes, primary prevention ICD indication, coronary artery disease and dilatative cardiomyopathy (each p = n.s.).
In ROC analysis, plasmatic NT-proBNP showed promising predictive values regarding AFib (AUC: 0.80, IQR 0.76-0.85, p < 0.001) as well as urinary NT-proBNP (AUC: 0.76, IQR 0.71-0.81, p < 0.001). There was no significant difference between plasmatic and urinary NT-proBNP according to ROC analysis (p = n.s.).
Plasmatic NT-proBNP was shown as a significant predictor regarding existence of atrial fibrillation in binary logistic regression analysis, beside age (p < 0.05). Diabetes, hypertension, serum creatinine, LVEF, coronary artery disease and primary prevention ICD indication were no significant predictors (p = n.s.). Urinary NT-proBNP was not shown as a significant predictor regarding existence of atrial fibrillation in binary logistic regression analysis (p = n.s.).
Conclusion
Elevated levels of plasmatic NT-proBNP are strongly associated with the prevalence of atrial fibrillation in a cohort of ICD patients.
Oxford University Press (OUP)
Title: Plasmatic NT-proBNP is strongly associated with atrial fibrillation in patients with Implantable cardioverter defibrillator
Description:
Abstract
Background and objectives
Atrial fibrillation is common in patients with chronic heart failure and associated with poor outcome in these patients.
Plasmatic NT-proBNP represents the gold standard biomarker for chronic heart failure.
Further, recent studies showed prognostic impact of urinary NT-proBNP.
Aim of the study was to assess the association of plasmatic as well as urinary NT-proBNP and atrial fibrillation in a cohort of patients with implantable cardioverter defibrillator (ICD).
Methods
412 patients were included in the study.
Fresh spot urine and blood samples were used to assess urinary as well as plasmatic NT-proBNP.
Urinary NT-proBNP was normalized to urinary creatinine.
Follow-up was performed after 45 months.
Heart rhythm history was evaluated and a 12-lead electrocardiogram was performed at enrollment (sinus rhythm (SR, n = 306), atrial fibrillation (AFib, n = 79)).
Results
Patients suffering from atrial fibrillation showed significant higher age, reduced left ventricular ejection fraction (LVEF), higher rates of chronic kidney disease, hypertension and urinary as well as plasmatic NT-proBNP compared to patients with sinus rhythm (each p < 0.
05).
There were no differences regarding Diabetes, primary prevention ICD indication, coronary artery disease and dilatative cardiomyopathy (each p = n.
s.
).
In ROC analysis, plasmatic NT-proBNP showed promising predictive values regarding AFib (AUC: 0.
80, IQR 0.
76-0.
85, p < 0.
001) as well as urinary NT-proBNP (AUC: 0.
76, IQR 0.
71-0.
81, p < 0.
001).
There was no significant difference between plasmatic and urinary NT-proBNP according to ROC analysis (p = n.
s.
).
Plasmatic NT-proBNP was shown as a significant predictor regarding existence of atrial fibrillation in binary logistic regression analysis, beside age (p < 0.
05).
Diabetes, hypertension, serum creatinine, LVEF, coronary artery disease and primary prevention ICD indication were no significant predictors (p = n.
s.
).
Urinary NT-proBNP was not shown as a significant predictor regarding existence of atrial fibrillation in binary logistic regression analysis (p = n.
s.
).
Conclusion
Elevated levels of plasmatic NT-proBNP are strongly associated with the prevalence of atrial fibrillation in a cohort of ICD patients.
Related Results
The effects of age on quality of life in implantable cardioverter defibrillator recipients
The effects of age on quality of life in implantable cardioverter defibrillator recipients
Background. The implantable cardioverter defibrillator shows superiority over conventional pharmacological therapy. The implantable cardioverter defibrillator has been implanted w...
Inter‐Relationships Between Atrial Flutter and Atrial Fibrillation
Inter‐Relationships Between Atrial Flutter and Atrial Fibrillation
It has been appreciated for a long time that atrial flutter and atrial fibrillation have a clinical relationship. Now, with the technological advances that permit more sophisticate...
NT-proBNP in severe aortic valve stenosis: necessity for higher cut-off values regarding congestive heart failure detection in atrial fibrillation
NT-proBNP in severe aortic valve stenosis: necessity for higher cut-off values regarding congestive heart failure detection in atrial fibrillation
Abstract
Background
NT-proBNP is an established biomarker for the determination of fluid overload. Patients suffering from atria...
Adiponectin and Lone atrial fibrillation
Adiponectin and Lone atrial fibrillation
Objective: Lone atrial fibrillation is an idiopathic arrhythmia seen in younger individuals without any secondary disease. Adiponectin is an endogenous adipocytokine that increases...
Beyond Coronary Risk: Clinical Scores as Predictors of Atrial Fibrillation in Chronic Coronary Syndrome
Beyond Coronary Risk: Clinical Scores as Predictors of Atrial Fibrillation in Chronic Coronary Syndrome
Atrial fibrillation frequently coexists with chronic coronary syndrome, sharing common cardiovascular risk factors and pathophysiological mechanisms. Identifying patients with chro...
ASSA13-03-9 Decreased Expression of Small-Conductance Ca2+-Activated K+ Channels SK1, SK2, and SK3 in Patients with Persistent Atrial Fibrillation
ASSA13-03-9 Decreased Expression of Small-Conductance Ca2+-Activated K+ Channels SK1, SK2, and SK3 in Patients with Persistent Atrial Fibrillation
Background
Small-conductance Ca2+-activated K+ channels (SK channels) have been reported involved in atrial fibrillation (AF) as a new ion channel candidates, as ...
PROGNOSTIC VALUE OF NT-PROBNP COMPLEMENTS THE GEACE SCORE IN PEOPLE WITH NON-ST-SEGMENT ELEVATION ACUTE CORONARY SYNDROME
PROGNOSTIC VALUE OF NT-PROBNP COMPLEMENTS THE GEACE SCORE IN PEOPLE WITH NON-ST-SEGMENT ELEVATION ACUTE CORONARY SYNDROME
Objectives
This study was designed to investigate whether admission N-terminal pro-brain natriuretic peptide (NT-proBNP) increase the prognostic accuracy of Globa...
Left atrial appendage anatomy and function: short term response to sustained atrial fibrillation
Left atrial appendage anatomy and function: short term response to sustained atrial fibrillation
OBJECTIVE
To determine whether there is significant atrial or atrial appendage enlargement or functional remodelling as a result of one to two months of sustained...

